Trial intelligence / Profile preview

NeoCart vs. Microfracture for Articular Cartilage Injuries in the Knee

NCT00548119Phase 2Completed

Sponsor
Histogenics
Start
Dec 2006
Primary completion
Nov 2009
Countries
1
01

Overview

A Phase 2 trial of NeoCart in Articular cartilage damage, sponsored by Histogenics. Started Dec 2006; status: completed.

02

Drugs

NeoCart
03

Conditions

Articular cartilage damage

Beyond the preview

Go deeper on NCT00548119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00548119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call